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Objectives: Inflammatory stimuli or mechanical stresses associated with
hypothermic cardiopulmonary bypass could potentially impair cerebrovas-
cular function, resulting in inadequate cerebral perfusion. We hypothesize
that hypothermic cardiopulmonary bypass is associated with endothelial or
vascular smooth muscle dysfunction and associated cerebral hypoperfu-
sion. Therefore we studied the cerebrovascular response to endothelium-
dependent vasodilator, acetylcholine, endothelium-independent nitric oxide
donor, sodium nitroprusside, and vasoactive amine, serotonin, in newborn
lambs undergoing hypothermic cardiopulmonary bypass (nasopharygeal
temperature 5 18° C). Methods: Studies were performed on 13 newborn
lambs equipped with a closed cranial window, allowing for direct visual-
ization of surface pial arterioles. Six animals were studied while undergoing
hypothermic cardiopulmonary bypass, whereas seven served as nonbypass,
warm (37° C) controls. Pial arteriolar caliber (range 5 111 to 316 mm
diameter) was monitored using video microscopy. Results: Topical applica-
tion of acetylcholine caused a dose-dependent increase in arteriolar diam-
eter in the control group that was absent in animals undergoing hypother-
mic cardiopulmonary bypass. Hypothermic cardiopulmonary bypass did
not alter the vasodilation in response to sodium nitroprusside. Further-
more, the contractile response to serotonin was fully expressed during
hypothermic cardiopulmonary bypass. Conclusions: The specific loss of
acetylcholine-induced vasodilation suggests endothelial cell dysfunction
rather than impaired ability of vascular smooth muscle to respond to nitric
oxide. It is speculated that loss of endothelium-dependent regulatory
factors in the cerebral microcirculation during hypothermic cardiopulmo-
nary bypass may enhance vasoconstriction, and impaired cerebrovascular
function may be a basis for associated neurologic injury during or after
hypothermic cardiopulmonary bypass. (J Thorac Cardiovasc Surg 1998;
115:1047-54)
Cerebral vasoparesis is believed to play a majorrole in causing cerebral injury in patients under-
going hypothermic cardiopulmonary bypass
(HCPB).1, 2 During HCPB, autoregulation, usually
preserved at temperatures greater than 22° C, is lost
with profound hypothermia. This is an important
consideration in infants and children in whom hy-
pothermia in the range of 16° to 18° C is commonly
achieved. In addition, reduced cerebral perfusion
persistent after rewarming/reperfusion, “no-reflow,”
has been described in patients exposed to HCPB.3, 4
These reports are suggestive of HCPB-associated
derangements of cerebrovascular regulatory mech-
anisms. Nevertheless, the mechanism(s) by which
HCPB induces cerebrovascular dysfunction is not
known.
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Studies of noncerebral arteries suggest that endo-
thelium-dependent responses are specifically im-
paired in animals undergoing HCPB.5-8 However,
similar data for the cerebral circulation are lacking
because of the unique characteristics of the cerebro-
vascular bed, which make it difficult to study (i.e., its
anatomic inaccessibility and the presence of the
blood-brain barrier).9 In this regard, the closed
cranial window technique circumvents some of these
problems, allowing direct assessment of function of
cerebral resistance arterioles in vivo. This study used
the closed cranial window technique to investigate
specific functional aspects of the pial circulation in a
neonatal lamb model undergoing HCPB, testing the
hypothesis that HCPB is associated with impaired
endothelial function in cerebral resistance vessels.
Methods
All animals received humane care in compliance with
the “Guide for the Care and Use of Laboratory Animals”
prepared by the National Academy of Sciences and pub-
lished by the National Institutes of Health (NIH publica-
tion No. 96-03, revised 1996), and the experimental pro-
tocol was approved by the Institutional Animal Care and
Use Committee at the Allegheny University of the Health
Sciences. Animals were preassigned to one of two groups
as described below; in brief, one group would be studied
while undergoing HCPB and the control group would be
instrumented for HCPB but not connected to the bypass
circuit. However, this selection was subject to hazard
distribution (i.e., dependent on availability of perfusion-
ists). Thus the selection of animals was not random but,
nevertheless, there was no possibility of investigator bias
in animal selection.
Animal preparation. Experiments were carried out on
13 newborn lambs 1 to 7 days of age. After induction of
anesthesia (20 mg/kg ketamine 1 1 mg/kg diazepam,
intramuscularly), a vertical incision was made in the groin
and the femoral artery and vein were cannulated for
continuous sedation (6 mg/kg per hour ketamine 1 0.15
mg/kg per hour diazepam) and intravenous fluid admin-
istration (5% glucose at 12 ml/hr). A vertical incision was
made in the midline of the neck, and the right carotid
artery was dissected free and encircled with 2-0 silk suture.
A transverse incision was made between the second and
third tracheal rings, and a 4 to 5 cm endotracheal tube was
inserted and secured with umbilical tape ties. The animal
was mechanically ventilated, positive end-expiratory pres-
sure 5 3 to 4 cm water and inspired oxygen fraction 5
0.21 to 0.60 to ensure end-expired carbon dioxide was
maintained between 35 and 40 mm Hg and arterial oxygen
tension (PO2) more than 200 mm Hg. Nasopharyngeal
temperature was monitored using thermocouples in all
cases and, in some preparations, a thermocouple was
placed into the subdural space to monitor brain temper-
ature. Arterial blood was sampled periodically from the
femoral artery cannula and checked for pH, carbon
dioxide tension (PCO2), PO2, and electrolytes by use of
conventional electrodes (NOVA Biomedical, Waltham,
Mass.).
A cranial window was inserted over the left cerebral
hemisphere (contralateral to the side of carotid artery
cannulation) as previously described.10 The animal’s head
was placed into a stereotaxic device and the scalp removed
to expose the left parietal portion of the skull. A hole
approximately 2 cm in diameter was made in the parietal
plate, and the dura was carefully removed to expose the
cerebral cortex. A cranial window was inserted into the
hole, the edges were sealed with bone wax, and the device
was cemented into place with dental acrylic as illustrated
in Fig. 1. The space under the window was filled with
artificial cerebrospinal fluid (CSF) of the following com-
position (mmol/L): KCl (2.9), MgCl2 (1.4), CaCl2 (1.2),
NaCl (132), NaHCO3 (24.6), urea (6.7), and glucose (3.7),
equilibrated with 6% carbon dioxide, 6% oxygen, at 37° C
(control group) or 20° C (HCPB group). Pial arteries were
visualized with a trinocular stereomicroscope (model
M3Z, Wild, Heerbrugg, Switzerland) attached to a high-
resolution CDC video camera (model LX-450A, Optron-
ics Engineering, Goleta, Calif.). The video image was
recorded on video tape and intraluminal diameter (red
cell column width) measured directly from the television
screen after calibration with a stage micrometer. The pial
arteries studied ranged in size from 111 to 316 mm in
diameter. One arteriole was studied in each animal.
After the cranial window had been secured, the animals
were instrumented for cardiopulmonary bypass. After the
administration of heparin (2 mg/kg, intravenously), the
right carotid artery was cannulated with a 10F cannula.
Through a right anterolateral thoracotomy in the third
intercostal space, the pericardium was opened in front of
the phrenic nerve and the right atrium was cannulated
with an 18F cannula. In six experimental animals mechan-
ical ventilation was discontinued and normothermic car-
diopulmonary bypass was initiated at a flow rate of 100 to
150 ml/kg per minute. A membrane oxygenator (Minntech
400) was primed with 100 to 200 ml (depending on the size
of the animal) of fresh sheep blood. Hematocrit was
approximately 45% at initiation and was decreased as
temperature decreased, achieving 21% to 22% at 18° C.
No arterial filters were used. Systemic hypothermia was
induced by core cooling to achieve 18° C nasopharyngeal
temperature over a period of 30 minutes. Alpha-stat
strategy was followed for acid-base management. Cardio-
Fig. 1. Schematic diagram of a closed cranial window.
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pulmonary bypass flow was adjusted to maintain a range
of mean arterial pressure ($50 mm Hg) desired for
evaluation of pial arteriolar reactivity during HCPB. The
other seven animals were continued on mechanical venti-
lation and served as nonbypass warm controls.
Experimental protocols. The pial arteriolar response to
acetylcholine (ACh), an endothelium-dependent vasodi-
lator, sodium nitroprusside (SNP), an endothelium-inde-
pendent vasodilator, and serotonin, a vasoconstrictor
amine, was evaluated as follows. Once the animal had
achieved a steady state (i.e., stabilized blood pressure,
blood gases, core temperature, and pial arteriolar diame-
ter) the cortical surface under the window was suffused
with artificial CSF (1 to 2 ml) by flushing into one port in
the window and out another port, filling the space under
the window without changing intracranial pressure. The
ports were then closed and arteriolar diameter recorded.
After 5 minutes, artificial CSF was replaced sequentially
by increasing concentrations of ACh (1027 mol/L, 1026
mol/L, and 1025 mol/L in artificial CSF) for 5 minutes
each. After this, the cortical surface was washed repeat-
edly (three to four times each 5 minutes) with artificial
CSF. After recovery, dose-response curves to subsequent
compounds (SNP or serotonin) were determined in simi-
lar fashion. The order by which the respective vasoactive
compounds were administered in each animal was ran-
domized. All three compounds were evaluated in three of
the control animals and four of the HCPB animals.
Statistical analysis. All values are presented as
mean 6 standard error of the mean For variables of
interest (i.e., pial diameters and their percent changes)
95% confidence intervals were calculated for the individ-
ual groups and are presented as appropriate. The data
were analyzed using two-way analysis of variance with one
repeated measure (SigmaStat Statistical Software, Jandel
Scientific, San Rafael, Calif.). The repeated measure was
drug doses because these were administered sequentially
to each animal. When the F value was significant, Student-
Newman-Kuels test was used to test for significant differ-
ences between individual means.
Results
The control group and HCPB groups had a mean
body weight of 6.4 6 0.5 kg and 7.3 6 1.0 kg,
respectively. Table I compares the hemodynamic
and blood gas status of control and HCPB groups at
the time of the respective dose-response determina-
tions to ACh, SNP, and serotonin. Mean arterial
blood pressure, arterial pH, and arterial PCO2 and
PO2 were not different between the two groups with
the exception of PCO2, which was higher in the
HCPB group during the serotonin administration.
Fig. 2 shows two representative experiments from
a control and a HCPB animal illustrating the pial
artery diameter (top) and mean arterial blood pres-
sure (bottom) during suffusion of ACh onto the
cortical surface. Pial arteries typically exhibited a
maximal response, in this case dilation in the control
group, within 2 to 4 minutes of exposure to the test
drug. As shown in this example, mean arteriolar
blood pressure was not affected by the suffusion of
drugs onto the cortical surface. Under these condi-
tions (i.e., stable blood pressure and blood gases)
changes in pial artery caliber can be attributed to the
direct actions of the suffused compound.
The average changes in pial artery diameter in
response to ACh, SNP, and serotonin are summa-
rized in Table II and the relative response expressed
as percent change is illustrated in Fig. 3. Both ACh
and SNP stimulated vasodilation, expressed as a
dose-dependent increase in pial artery diameter, to
a maximum of 18% 6 6% and 19% 6 7% at the
highest concentration (10-5 mol/L). In the control
group (i.e., animals not undergoing bypass and at
37° C) ACh caused a dose-dependent increase in
pial artery diameter from 163 6 22 mm to a maxi-
mum of 190 6 18 mm. When the data were com-
pared in terms of absolute diameter, there was a
significant interaction between group and drug ef-
fects, indicating that the response to ACh was
dependent on the group treatment. When the re-
sponse was normalized as percent of the initial
diameter, the interaction term was no longer signif-
icant (p 5 0.171); however, there was a clear effect
Table I. Arterial blood pressure, blood gases, and pH of control and HCPB groups during challenge with ACh,
SNP, or serotonin
ACh SNP Serotonin
Control HCPB Control HCPB Control HCPB
MABP (mm Hg) 79 6 3 61 6 11 69 6 4 56 6 10 88 6 3 79 6 5
pH 7.37 6 0.04 7.39 6 0.05 7.38 6 0.04 7.39 6 0.06 7.38 6 0.03 7.33 6 0.04
Arterial PCO2 (mm Hg) 41 6 1 39 6 4 36 6 3 42 6 4 38 6 3 47 6 2*
Arterial PO2 (mm Hg) 211 6 51 227 6 19 205 6 51 245 6 17 225 6 48 239 6 28
N 6 5 5 4 7 5
Values are mean 6 standard error of the mean.
*Significantly different respective control group (p 5 0.028).
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of group treatment (Fig. 3). Thus the ACh-induced
vasodilation was lost in the HCPB-treated group. In
contrast, no significant group effect was noted for
SNP, and serotonin stimulated a dose-dependent
decrease in pial artery diameter (i.e., vasoconstric-
tion) amounting to 26% 6 4% decrease from base-
line at the highest concentration (10-5 mol/L).
In summary, HCPB at 18° C significantly attenu-
ated vasodilator response to ACh. However, no
significant attenuation was noted for the vasodilator
response to SNP or the vasoconstrictor response to
serotonin (Fig. 3). These negative findings are inter-
preted with caution, however, because of the low
numbers. Nevertheless, we can say with confidence
that both groups of animals responded potently and
thus the response was fully expressed for both SNP
and serotonin. This is in contrast to the findings for
ACh.
Discussion
This study has used the closed cranial window
preparation for analysis of cerebrovascular reactivity
in vivo in a perinatal animal model undergoing
HCPB. The advantage of this technique is that it
allows direct visualization and continuous measure-
ment of caliber of surface pial arterioles. As in this
study, it provides a means for direct application of
agents onto the perivascular surface, and thus reac-
tivity of cerebral vessels can be studied without the
complication of altered hemodynamic effects or
possible influence of blood-brain barrier function
that may occur with intravascular administration of
experimental substances. Pial arterioles are major
contributors of resistance to flow, and their re-
sponses are generally representative of the cerebral
circulation as a whole.9, 11 Active regulation of ce-
rebrovascular resistance is achieved by changes in
diameter at the level of resistance arterioles, where,
as predicted by Poiseuille’s law, resistance (R) is
inversely proportional to the fourth power of the
radius (r) of the artery (R'1/r4). However, when
applied in vivo, pial arteriolar diameter more closely
approximates R'1/r3.11 Nevertheless, it can be ap-
preciated that even small changes in diameter will
reflect significant changes in resistance to flow. The
magnitude of the responses to ACh (8% to 19%
dilation), SNP (5% to 23% dilation), and serotonin
(12% to 27% constriction) are similar to what is
Fig. 2. Representative tracing of mean arterial blood pressure (MABP), bottom, and pial arteriolar
diameter, top, during topical application of acetylcholine (ACh) from a control animal and an animal
undergoing HCPB procedure. Arrows indicate application of artificial cerebral spinal fluid (CF) or ACh in
cerebral spinal fluid at the indicated concentrations.
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noted in a number of species and comparable to the
normal physiologic response to a 10 to 20 mm Hg
increase in arterial PCO2.
9
Cerebrovascular dysfunction (i.e., loss of reactiv-
ity or “vasoparesis” during HCPB and/or vasospasm
after HCPB) is believed to play a major role in the
increased incidence of central nervous system injury
associated with cardiac operation.1 Our laboratory
has preliminarily reported loss of pial arteriolar
reactivity to blood pressure changes in neonatal
lambs undergoing HCPB,12 suggesting that im-
paired reactivity of these important cerebral resis-
tance arterioles contributes to loss of cerebral blood
flow autoregulation reported in human infants and
children during HCPB.2, 13
This study has attempted to characterize the
reported cerebrovascular dysfunction as expressed
in cerebral resistance arterioles during HCPB. Ac-
cordingly, this study examined the effect of HCPB
on cerebrovascular reactivity to three distinct vaso-
active stimuli of potential significance during HCPB,
testing the hypothesis that loss of cerebrovascular
function is specific to select physiologic or patho-
physiologic stimuli whose expression is modulated
by functional endothelium. ACh is widely used as a
receptor-mediated stimulus of endothelium-depen-
dent generation and release of classic endothelium-
derived relaxing factor (EDRF). There is substantial
evidence implicating nitric oxide (NO) or a closely
related NO-containing species as the most potent
EDRF, although clearly other EDRFs, especially
arachidonic acid metabolites, have been identi-
fied.14, 15 NO, which is synthesized from endogenous
L-arginine by calcium-dependent activation of endo-
thelial NO synthase, activates guanylate cyclase in
vascular smooth muscle cells, stimulating cyclic
guanosine monophosphate formation, which in-
duces relaxation.16 SNP is one of the nitrosovasodi-
lators that generate NO directly and thus activates
guanylate cyclase leading to vasodilation indepen-
dent of endothelial NO synthase. Serotonin, a vaso-
active amine, released by activated platelets is a
potent vasoconstrictor of cerebral arteries by means
of vascular 5-hydroxytryptamine2 receptors.
17 How-
ever, 5-hydroxytryptamine receptors on the endo-
thelium may also stimulate EDRF formation and
modulate the contractile response to the amine.
Clearly, EDRF/NO through its inhibitory influence
on vascular smooth muscle, platelet activation, and
adhesion properties is potentially important to the
maintenance of cerebrovascular function during or
after HCPB.
This study has shown that the vasodilator re-
sponse to ACh was completely lost in those animals
undergoing HCPB, whereas the vasodilator re-
sponse to SNP was not affected. This indicates that
the injury was at the level of the endothelium,
whereas the capacity for vascular smooth muscle to
relax in response to NO remained intact. At the
same time the ability of the cerebral arteries to
contract in response to serotonin was fully expressed
during HCPB. It may also be concluded that cere-
bral “vasoparesis” is perhaps a misnomer or re-
quires qualification when applied to HCPB because
vasorelaxation as well as vasoconstriction to specific
stimuli could be demonstrated. HCPB appears to
cause selective loss of functional reactivity, and
cerebral autoregulation and endothelium-depen-
Table II. Pial arteriolar diameter (mm) of control and HCPB groups in response to topical challenge with
ACh, SNP, or serotonin
Concentration (mol/L)
ACh SNP Serotonin
Control HCPB Control HCPB Control HCPB
Baseline 163 6 22 168 6 3 173 6 26 147 6 31 172 6 14 171 6 37
(55) (85) (75) (99) (35) (102)
107 m 174 6 20 169 6 33 182 6 27 156 6 34 152 6 14* 141 6 10*
(51) (92) (75) (109) (34) (111)
106 m 185 6 19* 172 6 31† 190 6 22* 176 6 37* 132 6 13* 128 6 35*
(49) (87) (61) (118) (32) (97)
105 m 190 6 18* 168 6 31† 202 6 21* 179 6 39* 124 6 9* 125 6 31*
(47) (85) (58) (124) (22) (86)
N 6 5 5 4 7 5
Values are mean 6 standard error of the mean. Values in parentheses are 95% confidence intervals. There was a significant interaction term for acetylcholine
(group vs concentration, p 5 0.032). For SNP and serotonin, significant concentration effects were noted (p , 0.0001 and 0.0001, respectively); there were
no significant group effects (p 5 0.606 and 0.631, respectively).
*Significantly different from the respective group baseline (p # 0.05, by Student-Newman-Kuels test).
†Significantly different from respective control group (p # 0.05, by Student-Newman-Kuels test).
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dent relaxation appear to be most readily demon-
strable. Finally, we may conclude that cerebrovascu-
lar dysfunction during HCPB is expressed at the
level of resistance arterioles visualized by the cranial
window method, which may offer a new experimen-
tal approach to dissect the pathologic condition of
HCPB.
Various pathologic conditions, including fluid
percussion brain injury, acute hypertension, oxidant
injury, air emboli, and ischemia/reperfusion, are
associated with loss of relaxation response to ACh
and other endothelium-dependent stimuli. Simi-
larly, vascular pathophysiologic states associated
with atherosclerosis, diabetes mellitus, immaturity,
and aging often result in impaired endothelium-
dependent reactivity. Similarly, studies of isolated
femoral arteries and coronary and pulmonary circu-
lation have shown loss of endothelium-dependent
responses after HCPB, suggesting that reperfusion
and/or rewarming may be associated with endothe-
lium injury as well.5-8 However, the results of this
study showed that endothelium-dependent relax-
ation to ACh was impaired during HCPB before
rewarming/reperfusion and suggests that rewarming/
reperfusion is not necessarily the cause of the associ-
ated loss of the endothelium-dependent relaxation.
This study cannot otherwise identify specific fac-
tors that may have contributed to the impaired
responses observed. One suggested mechanism is
endothelial injury through gaseous microemboli that
are frequently produced during cardiopulmonary
bypass operations.18, 19 However, in one study of
femoral arteries, the magnitude of the functional
impairment of endothelium-dependent relaxation
was not correlated with the number of microemboli
generated.6 Another potential cause of impaired
endothelium might result from the multitude of
inflammatory mediators released during cardiopulmo-
nary bypass, such as bradykinin, complement, cyto-
kines, and reactive oxygen species, the latter of which
is well known to interfere with endothelium-depen-
dent relaxation.20 Extracorporeal oxygenation also
triggers platelet aggregation, and platelet aggregation
itself may damage cerebrovascular endothelium.21
Another significant factor altering cerebral reac-
tivity may be hypothermia. The specific effect of
deep hypothermia on cerebrovascular function is
difficult to assess in vivo because of the profound
decrease in cerebral oxygen consumption and asso-
ciated decrease in cerebral blood flow. In isolated
rat jugular vein, tissue cooling to 20° C attenuated
the relaxation response to ACh and enhanced the
contraction response to serotonin, showing that
endothelial mechanisms do contribute to a cold-
induced modification of reactivity.22 Isolated cere-
bral arteries from newborn lambs in tissue bath
Fig. 3. Effect of HCPB procedure on pial arteriolar responses. Data are presented as percent of baseline
diameter (see Table II). Error bars represent standard error of the mean; light shaded area represents 95%
confidence intervals and dark shading represents their overlap. There was a significant difference between
control and HCPB groups for acetylcholine (p 5 0.036), but no significant group effects were noted for
sodium nitroprusside (p 5 0.268) or serotinin (p 5 0.304).
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contracted to cooling from 37° C to 21° C, where
contractile force varied inversely with bath temper-
ature.23 The cold-induced contraction appears to be
mediated by protein tyrosine-dependent pathways.24
SNP potently relaxed the cold-contracted cerebral
arteries. These data suggest that impaired endothe-
lium-dependent NO production may facilitate the
contractile response to hypothermia. Furthermore,
because cerebral vasoconstrictor responses were not
impaired during HCPB, loss of NO production may
set the stage for unmitigated vasoconstriction to
vasoconstrictor amines, which may be especially
potent in neonates.23, 25
It is perhaps notable that NO formation is report-
edly essential to the phenomenon of cerebral blood
flow autoregulation in some species. For example,
cerebral blood flow autoregulation is impaired by
NO synthase inhibitors in rats and cats and the
vasodilatation seen with breakthrough of autoregu-
lation depends on release of NO or an NO do-
nor.26, 27 Furthermore, endothelium-dependent NO
formation has been found to play a “permissive”
role with respect to cerebrovascular reactivity to
elevated arterial PCO2.
28 That is to say that certain
vasodilator responses are expressed in the presence
of basal levels of NO synthesis. In this role, rather
than directly mediating vasodilation, NO modulates
intracellular second messenger pathways, which per-
mit expression of the normal vascular reactivity.
This concept may provide a basis for understanding
mechanisms by which impairment of endothelial
function may influence cerebrovascular reactivity in
a broader sense and thus contribute to selective
cerebral vasoparesis.
In summary, this study has shown that HCPB
impairs cerebral microvascular function (i.e., causes
loss of endothelium-dependent vasodilation) but not
nonspecific “vasoparesis” because select vasodilator
and vasoconstrictor responses are preserved. It is
likely that endothelial dysfunction coupled with
preserved contractile capability may set the stage for
enhanced cerebral vasoconstriction with an in-
creased potential for cerebral hypoperfusion during
or after the HCPB procedure.
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Discussion
Dr. Frank W. Sellke (Boston, Mass.). Autoregulation is
determined mainly by endothelium-independent mecha-
nisms. One of those is myogenic contraction. In most
species the endothelium really does not play much of a
role, so I am not sure you can conclude that the loss of
autoregulation is due to endothelial dysfunction. Did you
look specifically at loss of autoregulation?
Dr. Russo. Thank you, Dr. Sellke. Clinical and experi-
mental evidence indicate that cerebral autoregulation is
lost at 22° C. Loss of cerebral autoregulation, variously
defined as “vasoparesis or vasospasm,” has been implied
in the pathophysiology of cerebrovascular dysfunction,
particularly in newborns and infants undergoing HCPB.
The question is whether, indeed, this so-called cerebral
vasoparesis occurs as a myogenic phenomenon or is
induced by an injury occurring at a different level. We
believe that the mechanism underlying this so-called
cerebrovascular spasm requires clarification. Better un-
derstanding of such mechanism might have potential
clinical implications.
Dr. Sellke. Was your examination done during bypass
or after bypass?
Dr. Russo. During bypass.
Dr. Sellke. Under hypothermic conditions?
Dr. Russo. We did the studies at 18° C HCPB.
Dr. Sellke. Did you examine the responses under nor-
mothermic conditions?
Dr. Russo. Yes. We studied two groups of animals. The
control group underwent sham surgery at normothermia.
The study group underwent HCPB at 18° C. In the study
group cardiopulmonary bypass flow was adjusted so as to
maintain a range of mean arterial pressure around 50 mm
Hg, a level considered optimal for the evaluation of
cerebral autoregulation. One of the goals of the present
investigation was to confirm that indeed in our model
HCPB was associated with cerebral vasospasm as defined
in the literature.
Dr. Sellke. So the way I understand it, you are really
doing two things to these animals: you are putting them on
bypass and you are decreasing the temperature. Both of
these can have effects on vascular regulation. So your
control experiments were performed at normothermia
versus your experimental group, in which the vessels were
examined on bypass and under hypothermic conditions. Is
that right?
Dr. Russo. Yes, it is.
Dr. Sellke. I suspect it would be hard to look at just the
effects of hypothermia on vascular reactivity with this
preparation.
Dr. Russo. This was done in our laboratory. I would
refer to our work presented at the Society of Cardiovas-
cular Anesthesia in 1994. In that study we looked specif-
ically at the effect of hypothermia in vivo using this
preparation. Indeed, our first slide today is taken from
that study and it shows loss of cerebral autoregulation in
response to deep hypothermia. In other words, using the
cranial window preparation and modifying the mean
arterial blood pressure, we were able to confirm loss of
cerebral autoregulation in response to deep hypothermia.
Dr. Sellke. I am not saying that you are not losing
autoregulation because many investigators have shown
that. I am just not sure it is the endothelial dysfunction
that is causing it.
Dr. Russo. The objective of this study was not to
specifically show loss of autoregulation. We tried to
identify the mechanism by which this autoregulation is
lost.
Dr. Edward D. Verrier (Seattle, Wash.). I think one of
the questions Dr. Sellke is asking, though, is did you have
cardiopulmonary bypass as a variable independent of
hypothermia?
Dr. Russo. No, we did not have that.
Dr. Verrier. Because cardiopulmonary bypass itself in
such settings has also had the ability to affect endothelial
cell function and autoregulation. That has been done
many years ago.
Dr. Russo. Thank you, Dr. Verrier. That is correct.
However, we tried to identify the mechanism underlying
the so-called cerebral vasoparesis associated with HCPB.
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